NMPA Reclassifies Glucosamine Sulfate to OTC, Mandates Label Revisions
China’s National Medical Products Administration (NMPA) announced that potassium glucosamine sulfate has been reclassified from...
Policy / Regulatory
China’s JPO Launches VBP Round for Orthopedic Spine Consumables
China’s Joint Procurement Office (JPO) announced plans on July 11 to conduct a volume-based procurement...
China’s 7th VBP Round Yields 65.5% Drug Price Cuts, Foreign Firms Secure Bids
China’s 7th national volume-based procurement (VBP) round concluded with winning bids averaging a 65.5% price...
NMPA Issues New Vaccine Manufacturing and Distribution Rules
China’s National Medical Products Administration (NMPA) has released the “Vaccine Manufacturing and Distribution Management Measures,”...
NHSA Sets 2022 Goals for Basic Medical Insurance Funding and Reforms
The National Healthcare Security Administration (NHSA), Ministry of Finance (MOF), and State Taxation Administration (STA)...
China Establishes Leadership Group to Combat Drug-Related Crimes
China’s State Council executive body released a notification regarding the establishment of a leadership group...
Wuxi Biologics Set to Be Removed from US Restricted Trade List
Wuxi Biologics (HKG: 2269) is reportedly on the verge of being removed from a US...
CDE Releases 60th Batch of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 60th batch of chemical generic reference...
Guangdong Releases 2022 Non-Immunization Vaccine Catalog (7th Batch)
The Guangdong Provincial Center for Disease Control and Prevention and Guangdong Medicine Exchange jointly released...
NHC Releases Technical Guidelines for Drug Clinical Evaluation
The National Health Commission (NHC) has released the “Technical Guidelines for Comprehensive Clinical Evaluation of...
Hainan Medical Products Administration Issues Guidelines for Imported Drug Management
The Hainan Medical Products Administration (HMPA) has released a set of guidelines that took effect...
NMPA Releases Plans to Support HK and Macau Drug, Device Production in Mainland Cities
The National Medical Products Administration (NMPA) has released two implementation plans aimed at supporting Hong...
NMPA Releases 55th Batch of Reference Drugs for Generic Evaluation
The National Medical Products Administration (NMPA) has released the 55th batch of reference drugs for...
NMPA Releases Work Plans for Temporary Import of Urgently Needed Drugs
The National Medical Products Administration (NMPA) has officially released the “Work Plan for the Temporary...
Sun Pharma Loses VBP Bid for Bicalutamide in China Due to Quality Failures
The Shanghai Medical Products Administration (SMPA) has revoked the winning bid of India-based Sun Pharmaceutical...
NHSA Updates NRDL with Focus on Expert Review and Simplified Renewals
The National Healthcare Security Administration (NHSA) has released the “2022 National Reimbursement Drug List (NRDL)...
7th National VBP Round Venue Moved to Nanjing from Shanghai
In a departure from previous practice, the 7th national volume-based procurement (VBP) round will not...
Beijing Introduces White List System for Biomedical R&D Item Imports
Beijing has announced the introduction of a ‘white list’ system to facilitate the import of...
China’s Seventh National Volume-based Procurement Round Kicks Off with Revised Rules
China’s health authorities have resumed the seventh national volume-based procurement (VBP) round after a pandemic-related...
CDE Releases 58th and 59th Batches of Chemical Generic Reference Preparations
The Center for Drug Evaluation (CDE) has released the 58th and 59th batches of chemical...